EUVIMEDEUVIMED entdecken
Crossref

The efficacy and safety of anamorelin among patients with diabetes

Kenju Ando, Tateaki Naito, Satoshi Hamauchi, Keita Miura, Yuichiro Nishibori, Ayumi Tonsho, Suguru Matsuda, Meiko Morita, Motoki Sekikawa, Kosei Doshita, Hiroaki Kodama, Michitoshi Yabe und 11 weitere

International Journal of Clinical Oncology · 2024

DOI: 10.1007/s10147-024-02546-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Clinical Oncology, 2024. Verfasst von Kenju Ando und 22 weiteren Autor:innen. Beteiligte Einrichtung: Division of Thoracic Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-Cho, Sunto-gun, Shizuoka, 411-8777, Japan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Cachexia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2CachexiaHumansMaleFemaleAgedMiddle AgedRetrospective StudiesOligopeptidesNeoplasmsAged, 80 and overGlycated HemoglobinBlood GlucoseWeight GainReceptors, GhrelinTreatment OutcomeHydrazines

Stichwörter der Autor:innen

AnamorelinCancer cachexiaDiabetesHyperglycaemia

Substanzen

anamorelinOligopeptidesGlycated HemoglobinBlood GlucoseReceptors, GhrelinHydrazines

Autor:innen und Institutionen

  • Division of Thoracic Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-Cho, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Division of Thoracic Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-Cho, Sunto-gun, Shizuoka, 411-8777, Japan. t.naito@scchr.jp.
  • Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.

Zitieren

APA

Ando, K., Naito, T., Hamauchi, S., Miura, K., Nishibori, Y., Tonsho, A., Matsuda, S., Morita, M., Sekikawa, M., Doshita, K., Kodama, H., Yabe, M., Morikawa, N., Iida, Y., Mamesaya, N., Kobayashi, H., Ryo, K., Wakuda, K., Ono, A., …, & Takahashi, T. (2024). The efficacy and safety of anamorelin among patients with diabetes. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-024-02546-8

Vancouver

Ando K, Naito T, Hamauchi S, Miura K, Nishibori Y, Tonsho A, et al. The efficacy and safety of anamorelin among patients with diabetes. International Journal of Clinical Oncology. 2024. doi:10.1007/s10147-024-02546-8

BibTeX
@article{Ando2024,
  author = {Ando, Kenju and Naito, Tateaki and Hamauchi, Satoshi and Miura, Keita and Nishibori, Yuichiro and Tonsho, Ayumi and Matsuda, Suguru and Morita, Meiko and Sekikawa, Motoki and Doshita, Kosei and Kodama, Hiroaki and Yabe, Michitoshi and Morikawa, Noboru and Iida, Yuko and Mamesaya, Nobuaki and Kobayashi, Haruki and Ryo, Ko and Wakuda, Kazushige and Ono, Akira and Kenmotsu, Hirotsugu and Murakami, Haruyasu and Yamazaki, Kentaro and Takahashi, Toshiaki},
  title = {The efficacy and safety of anamorelin among patients with diabetes},
  journal = {International Journal of Clinical Oncology},
  year = {2024},
  doi = {10.1007/s10147-024-02546-8}
}
Kostenlos starten →